Illumina to divest cancer test maker Grail By Reuters
December 17, 2023
[ad_1]
© Reuters. FILE PHOTO: A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo
(Reuters) – Illumina (NASDAQ:) said on Sunday that it would divest cancer diagnostic test maker Grail.
[ad_2]
Source link
© Reuters. FILE PHOTO: A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo
(Reuters) – Illumina (NASDAQ:) said on Sunday that it would divest cancer diagnostic test maker Grail.
About The Author
